Receptor, ErbB-2, antagonists & inhibitors
- Receptor, ErbB-2, antagonists & inhibitors
- Accession Number
Drug Drug Description AV-412 Investigated for use/treatment in cancer/tumors (unspecified). Pertuzumab An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. Tesevatinib Tesevatinib has been used in trials studying the treatment of Cancer, Stomach Cancer, Brain Metastases, Esophageal Cancer, and Leptomeningeal Metastases, among others. Tesevatinib is a potent inhibitor of multiple RTKs... CP-724714 CP-724,714 has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasm Metastasis.
- Drugs & Drug Targets